Table 1 Comparison of baseline and intraoperative data between the two groups
Characteristic | Group A (n=50) | Group B (n=50) | P Value |
|---|---|---|---|
Age (y) | 68.1(4.3) | 66.9(3.4) | 0.120 |
BMI (kg/m2) | 23.8(3.4) | 23.6 (2.5) | 0.745 |
Gender (female), n (%) | 22(44.0) | 19 (38.0) | 0.542 |
PSQI0 (median, IQR) | 12.0 (10.8,14.0) | 11.5(9.0,13.0) | 0.071 |
Preoperative anxiety (SAS≥55), n (%) | 15(30) | 18(36) | 0.523 |
Preintervention clinical insomnia (ISI≥15), n (%) | 16 (32) | 18 (36) | 0.673 |
EF (%) | 63.3 (6.3) | 62.9 (7.3) | 0.759 |
Smoking, n (%) | 8(16.0) | 7 (14.0) | 0.779 |
Hypertension, n (%) | 29(58.0) | 27 (54.0) | 0.687 |
Diabetes, n (%) | 10(20.0) | 10(20.0) | - |
Anaemia, n (%) | 10(20.0) | 9 (18.0) | 0.799 |
MCI, n (%) | 8(16.0) | 6 (12.0) | 0.564 |
Type of procedure, n (%) | |||
Off-pump CABG, n (%) | 14(28.0) | 21(42.0) | 0.142 |
Valve or aortic root surgery, n (%) | 36(72.0) | 29(58.0) | |
Length of surgery (median, IQR, min) | 292.5(250.0,332.5) | 300.0(253.8,345.0) | 0.684 |
Anaesthetic duration (median, IQR, min) | 327.5(295.0, 397.0) | 357.5(307.5, 401.3) | 0.261 |
Sufentanil (median, IQR, µg) | 361.0 (321.0, 395.0) | 361.5 (341.0,407.5) | 0.569 |
Propofol (median, IQR, mg) | 1155.0(1012.0, 1337.0) | 1200.0(1015.8,1463.0) | 0.530 |
Serious event | |||
Serious hypotension, n (%) | 5(10.0) | 6(12.0) | 0.749 |
Cardiac arrest, n (%) | 0 (0) | 1 (1.1) | >0.999* |
Heavy bleeding, n (%) | 0 (0) | 0 (0) | - |